Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
27.08 57.84 16.52 37.69 57.39 50.55 39.49 35.52 45.87 41.40
Piotroski F-Score
7 5 3 5 3 8 6 7 6 5
P/S ratio
3.95 4.75 4.31 5.28 6.41 5.89 5.04 5.49 6.07 5.35
Altman Z-Score
4.26 4.56 3.85 4.31 3.90 4.54 4.18 4.76 5.30 4.81
Altman Z″-Score (non-manufacturers)
4.56 4.21 3.90 4.10 3.16 3.60 3.39 3.70 4.06 3.96
P/FCF ratio
31.35 61.45 28.77 50.92 32.98 36.82 45.70 35.86 39.34 31.36
Beneish M-Score
(2.34) (2.45) (2.28) (2.28) (2.72) (2.54) (2.32) (2.50) (2.57) (2.62)
P/Operating CF
67.90 86.97 56.06 106.83 74.38 100.82 92.77 73.59 71.04 62.68
Dividend Safety Score
— — — — — — — — — 82
P/B ratio
4.68 5.92 5.00 6.13 7.03 6.78 5.60 6.05 6.65 5.99
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 357.24 0.00
EV/Sales
4.26 5.10 4.76 5.72 7.18 6.45 5.65 5.97 6.47 5.82
EV/EBITDA
17.72 21.60 19.88 24.40 33.93 30.86 27.13 24.90 30.87 24.02
EV/Operating CF
25.17 40.72 24.83 38.88 31.42 33.80 39.70 32.98 34.48 28.96
EV/FCF
33.83 66.06 31.80 55.24 36.91 40.28 51.16 39.03 41.95 34.11
Quick Ratio
1.70 1.43 1.25 1.66 1.14 1.33 0.87 0.86 1.11 1.04
Current Ratio
2.50 2.29 2.02 2.51 1.93 2.20 1.63 1.58 1.95 1.89
Net Debt/EBITDA
1.30 1.51 1.89 1.91 3.61 2.65 2.90 2.02 1.92 1.93
Debt/Assets
33.83% 32.54% 36.21% 36.76% 40.75% 36.03% 35.38% 32.56% 31.64% 33.15%
Debt/Equity
0.72 0.72 0.84 0.87 1.07 0.84 0.79 0.70 0.66 0.71
Asset Turnover
0.62 0.58 0.55 0.52 0.45 0.50 0.52 0.53 0.55 0.55
Operating CF/Net income
1.16 1.53 0.73 1.05 2.05 1.64 1.11 1.17 1.42 1.55
Capex/Depreciation
(0.90) (0.93) (0.79) (0.83) (0.60) (0.53) (0.59) (0.56) (0.72) (0.64)
Interest Coverage
75.00 38.28 21.32 17.50 21.79 38.00 30.22 10.71 9.02 8.05
ROE
18.24% 10.45% 32.73% 16.98% 12.35% 14.26% 14.97% 17.98% 15.26% 15.08%
ROA
8.99% 4.79% 14.38% 7.26% 4.96% 5.78% 6.59% 8.24% 7.22% 7.15%
ROIC
10.39% 9.96% 8.86% 8.71% 5.78% 6.64% 6.40% 8.52% 7.75% 8.94%
Return on Tangible Assets
26.22% 15.73% 49.23% 22.58% 21.56% 24.02% 33.97% 40.51% 28.03% 29.95%
Average Days of Receivables
63.40 64.47 62.58 70.95 68.70 64.47 70.53 67.04 64.41 58.70
Research and Development Expense of Revenue
6.31% 6.32% 6.34% 6.52% 6.86% 7.22% 7.88% 6.77% 6.49% 6.46%
Selling, General and Administrative Expense of Revenue
36.53% 36.58% 37.49% 35.98% 37.36% 37.57% 34.61% 34.69% 34.01% 34.44%
Intangible Assets out of Total Assets
0.48 0.48 0.47 0.44 0.53 0.51 0.54 0.50 0.47 0.52
Share Based Compensation of Revenue
0.86% 0.91% 0.87% 0.85% 0.99% 1.00% 0.91% 1.00% 1.01% 0.97%
Graham Net Nets
(0.07) (0.07) (0.10) (0.08) (0.13) (0.10) (0.11) (0.08) (0.05) (0.08)
Graham Number
50.33 40.49 81.82 65.51 57.86 68.53 78.48 95.87 97.80 105.86
Earnings Yield
3.69% 1.73% 6.05% 2.65% 1.74% 1.98% 2.53% 2.82% 2.18% 2.42%
Free Cash Flow Yield
3.19% 1.63% 3.48% 1.96% 3.03% 2.72% 2.19% 2.79% 2.54% 3.19%
Revenue per Share
30.27 33.27 36.36 39.80 38.22 45.38 48.78 54.00 59.30 65.71
Operating CF per Share
5.12 4.17 6.98 5.86 8.73 8.66 6.94 9.78 11.13 13.20
Capex per Share
(1.31) (1.60) (1.53) (1.74) (1.30) (1.39) (1.55) (1.51) (1.98) (1.99)
Free Cash Flow per Share
3.81 2.57 5.45 4.12 7.43 7.26 5.38 8.26 9.15 11.21
Cash per Share
9.05 7.47 9.89 11.83 8.05 8.01 5.10 8.04 11.79 10.73
Shareholders Equity per Share
25.53 26.68 31.36 34.24 34.84 39.46 43.93 48.98 54.16 58.66
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
25.53 26.68 31.36 34.24 34.84 39.46 43.93 48.98 54.16 58.66
Free Cash Flow
1,425.00 961.00 2,038.00 1,542.00 2,790.00 2,738.00 2,036.00 3,136.00 3,487.00 4,283.00
Working Capital
4,713.00 4,508.00 4,926.00 6,658.00 4,666.00 5,468.00 3,972.00 4,597.00 7,231.00 6,961.00
Capital Expenditures
(490.00) (598.00) (572.00) (649.00) (487.00) (525.00) (588.00) (575.00) (755.00) (761.00)
Net Current Asset Value
(3,024.00) (4,224.00) (5,766.00) (6,302.00) (11,539.00) (9,737.00) (9,993.00) (8,801.00) (7,490.00) (10,669.00)
EV/EBIT
22.16 27.64 25.54 31.40 46.32 42.68 36.67 31.48 39.65 29.88
Capex to Sales
0.04 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03
Price to Operating Income
20.54 25.71 23.11 28.94 41.39 39.02 32.75 28.92 37.19 27.48
Other line items
Depreciation/Fixed assets
0.35 0.33 0.32 0.30 0.30 0.35 0.34 0.32 0.30 0.31
Cash ROIC
7.18% 4.81% 8.06% 5.44% 9.27% 9.01% 6.44% 9.05% 9.00% 10.11%
Accounts Receivable Turnover
6.24 5.98 6.00 5.70 5.13 5.98 5.60 5.59 5.83 6.26
Accounts Payable Turnover
9.02 9.23 8.23 7.85 7.13 6.33 5.41 5.08 5.10 5.20
Inventory Turnover
2.08 1.90 1.72 1.75 1.64 1.80 1.88 1.68 1.70 1.80
Average Days of Payables
41.74 41.69 50.57 47.49 55.85 67.11 75.06 74.42 75.15 72.55
Days of Inventory on Hand
193.92 211.00 231.31 209.66 240.90 197.00 212.22 237.59 213.67 214.14
Average Receivables
1,814.50 2,082.50 2,265.00 2,612.50 2,797.00 2,861.50 3,293.50 3,665.00 3,876.00 4,013.00
Average Payables
423.50 462.00 566.50 660.50 742.50 969.50 1,271.00 1,465.00 1,598.00 1,739.00
Average Inventory
1,834.50 2,247.50 2,710.00 2,967.50 3,237.00 3,404.00 3,654.50 4,419.00 4,808.50 5,042.00
Average Assets
18,329.00 21,316.00 24,713.00 28,698.00 32,248.50 34,480.50 35,757.50 38,398.00 41,441.50 45,407.50
Average Common Equity
9,030.50 9,765.00 10,855.00 12,268.50 12,945.50 13,980.50 15,746.50 17,604.50 19,613.50 21,527.00

Fold the line items

Columns are period end dates